Schafer Joshua

Track

Insider profile

Performance

Overall performance
3.3
Performance over holding periods
3.3
30 days 90 days 120 days
Average return 26% 8.2% 15.1%
Success rate 78% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Schafer Joshua's trades of Zevra Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
142.24
Quantity 58,015 +12.8%
Value US$1,603,427
Transaction date
Proposed sale
Price
7.72
Quantity 10,500
Value US$81,060
Transaction date
Purchase
Price
5.13
Quantity 500 +16.7%
Value US$2,564
Transaction date
Purchase
Price
4.61
Quantity 2,000 +inf%
Value US$9,218
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-04 2026-02-03
PlS Planned sale
69,012 +26.8%
424.29
US$1,134,331 		69,012 +26.8% 424.29 US$1,134,331
2026-02-02 2026-01-30
PlS Planned sale
58,015 +12.8%
142.24
US$1,603,427 		58,015 +12.8% 142.24 US$1,603,427
2026-01-30 2026-01-30
PrS Proposed sale
9,592
162.20
US$4,397,911 		9,592 162.20 US$4,397,911
2025-02-14 2025-02-13
PlS Planned sale
10,500 -26.3%
7.86
US$82,527 		10,500 -26.3% 7.86 US$82,527
2025-02-13 2025-02-13
PrS Proposed sale
10,500
7.72
US$81,060 		10,500 7.72 US$81,060
2023-09-06 2023-09-05
B Purchase
500 +16.7%
5.13
US$2,564 		500 +16.7% 5.13 US$2,564
2023-03-15 2023-03-14
B Purchase
2,000 +inf%
4.61
US$9,218 		2,000 +inf% 4.61 US$9,218